Pretraži

Vaši rezultati

Prikazuje se 9 od 9 rezultati

On 14 July 2022, the European Commission tabled a proposal to update and expand EU legislation on blood, tissues and cells. The aim is to establish high standards of quality and safety for substances of human origin (SoHOs) intended for human application, to improve the protection of donors, recipients, and offspring born from medically assisted reproduction, and to ensure that the legislation can respond to future challenges. The European Parliament's Committee on the Environment, Public Health ...

During its September session, Parliament is expected to vote on the report adopted by its Committee on the Environment, Public Health and Food Safety on a proposal to revise the EU laws on blood, tissues and cells. The proposal is a new step towards building a strong European health union. The report as voted would form Parliament's position for negotiations with the Council.

What if we could renew all our cells?

Kratki prikaz 20-11-2020

Regenerative medicine (RM) is an interdisciplinary field that applies engineering and life science techniques to restore tissues and organs damaged by age, disease or trauma, as well as those with congenital defects. Promising data supports the future capability of using RM across a wide array of organ systems and contexts, including surface wounds, cardiovascular diseases and traumas and treatments for certain types of cancer.

Organoids are artificially grown organs that mimic the properties of real organs. What new possibilities for treating diseases, drug development, and personalised and regenerative medicine do organoids provide?

This report summarises the presentations and discussions at the Workshop on Stem Cell Research and Patenting, held at the European Parliament in Brussels, on Monday 19 March 2012. The aim of the workshop was to better understand the scientific and legal issues surrounding stem cell research and patenting, in particular to improve awareness about the recent judgement of the Court of Justice of the European Union. The workshop was co-chaired by MEPs Glenis Willmott and Alojz Peterle.

This report summarises the presentations and discussions at the Workshop on Voluntary and Unpaid Donation of Tissues and Cells held at the European Parliament in Brussels on Tuesday 20 December 2011. The aim of the workshop was to gather input from specialists in different fields related to tissues and cell donation in order to learn more from their work and perspectives. The workshop was chaired by Marina YANNAKOUDAKIS, MEP.

Human embryo research is a well established feature of the modern scientific landscape. The technique has recently come to the fore in public policy debates because of new technological advances. Human embryo research now promises to play a pivotal role in the treatment of many chronic illnesses through developments in stem cell technology as well as continuing to offer hope for those who suffer from subfertility. Developments in the field of human stem cell research are, to a large degree, dependent ...